中外医疗
中外醫療
중외의료
CHINA FOREIGN MEDICAL TREATMENT
2014年
13期
3-4
,共2页
贺王伟%李卫华%谢强%唐蓉
賀王偉%李衛華%謝彊%唐蓉
하왕위%리위화%사강%당용
急性冠脉综合征%磺达肝癸钠%血液流变学
急性冠脈綜閤徵%磺達肝癸鈉%血液流變學
급성관맥종합정%광체간계납%혈액류변학
Acute coronary syndrome%Fondaparinux%Hemorheology
目的:研究磺达肝癸钠对急性冠脉综合征患者血液流变学的影响。方法将2011年1月—2012年12月期间该院收治的急性冠脉综合征患者纳入研究,随机分为给予常规治疗的对照组和给予常规治疗联合磺达肝癸钠治疗的观察组,采用血液流变学检测仪检测血液流变学指标。结果观察组红细胞聚集指数(1.4±0.2) vs (1.9±0.3)、毛细血管血浆黏度(1.2±0.1) vs (1.5±0.2)、全血黏度、全血还原黏度均低于对照。结论磺达肝癸钠有助于持久降低血粘度、改善血液流变学指标,具有积极的临床价值。
目的:研究磺達肝癸鈉對急性冠脈綜閤徵患者血液流變學的影響。方法將2011年1月—2012年12月期間該院收治的急性冠脈綜閤徵患者納入研究,隨機分為給予常規治療的對照組和給予常規治療聯閤磺達肝癸鈉治療的觀察組,採用血液流變學檢測儀檢測血液流變學指標。結果觀察組紅細胞聚集指數(1.4±0.2) vs (1.9±0.3)、毛細血管血漿黏度(1.2±0.1) vs (1.5±0.2)、全血黏度、全血還原黏度均低于對照。結論磺達肝癸鈉有助于持久降低血粘度、改善血液流變學指標,具有積極的臨床價值。
목적:연구광체간계납대급성관맥종합정환자혈액류변학적영향。방법장2011년1월—2012년12월기간해원수치적급성관맥종합정환자납입연구,수궤분위급여상규치료적대조조화급여상규치료연합광체간계납치료적관찰조,채용혈액류변학검측의검측혈액류변학지표。결과관찰조홍세포취집지수(1.4±0.2) vs (1.9±0.3)、모세혈관혈장점도(1.2±0.1) vs (1.5±0.2)、전혈점도、전혈환원점도균저우대조。결론광체간계납유조우지구강저혈점도、개선혈액류변학지표,구유적겁적림상개치。
Objective To study the effect of fondaparinux on hemorheology in treating acute coronary syndrome. Methods The a-cute coronary syndrome patients admitted in our hospital from January, 2011 to December, 2012 were enrolled in the study and randomly divided into the control group and the observation group. The control group was given the conventional treatment, while the observation group was given the conventional treatment combined with fondaparinux. The hemorheology indexes were detected by hemorheological instrument. Results The red cell assembling index(1.4±0.2 vs 1.9±0.3), blood capillary plasma viscosity(1.2± 0.1 vs 1.5±0.2), whole blood viscosity, whole blood reduced viscosity of the observation group were lower than those of the control group. Conclusion Fondaparinux has positive clinical value for it can reduce blood viscosity and improve the hemorheology indexes.